Discontinuation report HEPARIN SODIUM INJECTION USP

Last updated on 2017-04-02 History
Report ID 1448
Drug Identification Number 02382296
Brand name HEPARIN SODIUM INJECTION USP
Common or Proper name HEPARIN
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) HEPARIN SODIUM
Strength(s) 1000UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS
Packaging size 25 x 10ML
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for discontinuation Other (Please describe in comments)
Anticipated discontinuation date
Actual discontinuation date 2017-04-01
Remaining supply date 2017-04-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Discontunation of product / Discontinuité du produit
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2017-04-02 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare